Jia Liu. Clarifying Transfusion Endpoint and Safety Reporting in the Phase III rhTPO Trial. // American Journal of Hematology. – 2026. – DOI: 10.1002/ajh.70527. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ajh.70527?af=R
Jia Liu (2026). Clarifying Transfusion Endpoint and Safety Reporting in the Phase III rhTPO Trial. American Journal of Hematology. https://doi.org/10.1002/ajh.70527
Jia Liu. “Clarifying Transfusion Endpoint and Safety Reporting in the Phase III rhTPO Trial.” American Journal of Hematology, 2026. doi:10.1002/ajh.70527.
@article{Liu2026,
title = {Clarifying Transfusion Endpoint and Safety Reporting in the Phase III rhTPO Trial},
author = {Liu, Jia},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70527},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ajh.70527?af=R}
}